The Veteran's tinea versicolor and tinea cruris are currently rated at 30 percent prior to April 9, 2021, and at 60 percent thereafter. The Board has found that the previous rating decisions did not become final due to new and material evidence submitted by the Veteran. The case is remanded for further development including an examination to determine the percentage of body area affected by tinea versicolor.
The deciding factor: The VA examinations conducted were insufficient to accurately assess the extent of the Veteran's skin condition, as they did not review all relevant photographs and lay statements regarding flare-ups.
- Claimed conditions
- tinea versicolor, tinea cruris
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- November 4, 2021
- Citation
- 21067461
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 21067461.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board is remanding the claim for tinea versicolor to ensure that VA fulfills its duty to assist by obtaining private medical records and potentially scheduling a new examination.
- Granted
The Board granted service connection for enlarged liver (fatty infiltration), benign prostate hypertrophy, and tinea versicolor as secondary to the Veteran's service-connected diabetes mellitus, type II.
- Partly granted
The Board granted readjudication for the claims of service connection for left foot hallux valgus and tinea versicolor, but denied the claims for tinea corporis, tinea cruris, carbuncle, cyst, and scarring secondary to tinea versicolor.
- Partly granted
The Board granted a 10 percent disability rating for dermatitis, variously diagnosed as seborrheic dermatitis, dermatophytosis, and tinea versicolor, prior to June 5, 2023, but denied a higher rating from that date. The issues related to Raynaud's syndrome and special monthly compensation were remanded.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.